Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS Med, 21
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial.
Luvira V. et al, (2024), BMC Infect Dis, 24
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
Schilling WHK. et al, (2024), Lancet Infect Dis, 24, 36 - 45
Comparing the roles of community health workers for malaria control and elimination in Cambodia and Tanzania.
Adhikari B. et al, (2023), BMJ Glob Health, 8
The feasibility of novel point-of-care diagnostics for febrile illnesses at health centres in Southeast Asia: a mixed-methods study.
Adella FJ. et al, (2023), Trans R Soc Trop Med Hyg, 117, 788 - 796
Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications.
Conradis-Jansen F. et al, (2023), Malar J, 22
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV).
Schilling WHK. et al, (2023), Elife, 12
Village malaria workers for the community-based management of vivax malaria.
Adhikari B. et al, (2023), Lancet Reg Health Southeast Asia, 9
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.
Tripura R. et al, (2023), Lancet Infect Dis, 23, 81 - 90
Expanding the role of village malaria workers in Cambodia: Implementation and evaluation of four health education packages.
Betrian M. et al, (2023), PLoS One, 18
Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia.
Adhikari B. et al, (2022), Malar J, 21
Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19
Schilling WHK. et al, (2022)